207 related articles for article (PubMed ID: 2803403)
21. [What role does eosinophil cationic protein have in the evaluation of asthma severity?].
Nieto A
Allergol Immunopathol (Madr); 2000; 28(3):119-24. PubMed ID: 10867382
[TBL] [Abstract][Full Text] [Related]
22. Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children.
Niggemann B; Kleinau I; Schmitt M; Wahn U
Allergy; 1994 Feb; 49(2):74-80. PubMed ID: 8172362
[TBL] [Abstract][Full Text] [Related]
23. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
24. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course.
Skedinger M; Halldén G; Lundahl J; Hed J; Zetterström O
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):250-5. PubMed ID: 7552927
[TBL] [Abstract][Full Text] [Related]
25. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
26. [Serum eosinophil cationic protein, urinary eosinophil protein X and urinary N-methylhistamine during acute asthma in children].
Shirakawa S; Iwasaki E; Miyabayashi Y; Baba M
Arerugi; 1998 Dec; 47(12):1240-7. PubMed ID: 10028717
[TBL] [Abstract][Full Text] [Related]
27. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
Kobayashi H; Maeda S; Tamura M; Sakamoto S
Nihon Rinsho; 1993 Mar; 51(3):626-30. PubMed ID: 8492435
[TBL] [Abstract][Full Text] [Related]
28. [Bronchial asthma pediatric field].
Shibasaki M; Takeda K
Nihon Rinsho; 1993 Mar; 51(3):759-64. PubMed ID: 8492454
[TBL] [Abstract][Full Text] [Related]
29. Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children.
Van Bever HP; Moens MM; Bridts CH; De Clerck LS; Mertens AV; Bosmans E; Stevens WJ
Allergy; 1993 Aug; 48(6):443-9. PubMed ID: 8238800
[TBL] [Abstract][Full Text] [Related]
30. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
31. Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen.
Alvarez MJ; Echechipía S; García B; Tabar AI; Martín S; Rico P; Olaguibel JM
Clin Exp Allergy; 2002 Nov; 32(11):1574-82. PubMed ID: 12569977
[TBL] [Abstract][Full Text] [Related]
32. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
Grutters JC; Brinkman L; Aslander MM; van den Bosch JM; Koenderman L; Lammers JW
Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242
[TBL] [Abstract][Full Text] [Related]
33. Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma.
Roquet A; Halldén G; Ihre E; Hed J; Zetterström O
Allergy; 1996 Jul; 51(7):482-8. PubMed ID: 8863925
[TBL] [Abstract][Full Text] [Related]
34. Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response.
Schmekel B; Venge P
Allergy; 1993; 48(17 Suppl):94-7; discussion 110-1. PubMed ID: 8109720
[TBL] [Abstract][Full Text] [Related]
35. Surplus value of eosinophil count and ECP to diagnose and monitor asthmatic patients.
Pronk-Admiraal CJ; Haitjema T; Horikx P; Bartels PC
Neth J Med; 2001 Jan; 58(1):9-17. PubMed ID: 11137745
[TBL] [Abstract][Full Text] [Related]
36. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population.
Björnsson E; Janson C; Håkansson L; Enander I; Venge P; Boman G
Allergy; 1994 Oct; 49(9):730-6. PubMed ID: 7695062
[TBL] [Abstract][Full Text] [Related]
37. Predictors of early- and late-phase reactions to bronchial allergen challenge.
Haugaard L; Iversen M; Dahl R
Allergy; 1997 Oct; 52(10):999-1004. PubMed ID: 9360751
[TBL] [Abstract][Full Text] [Related]
38. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy.
Tang RB; Chen SJ
Pediatr Pulmonol; 2001 Feb; 31(2):121-5. PubMed ID: 11180687
[TBL] [Abstract][Full Text] [Related]
40. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Griffin E; Håkansson L; Formgren H; Jörgensen K; Peterson C; Venge P
J Allergy Clin Immunol; 1991 Feb; 87(2):548-57. PubMed ID: 1847158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
